The UK was the first country to introduce the meningitis C conjugate (MenC) vaccine. Since 1999, the MenC vaccine has been part of the routine childhood immunisation programme and uptake levels have been close to 90%. The programme, targeted at under-20 year olds, has been a huge success, with a 90% reduction in cases in that age group. However, young adults between 20 and 24 years of age and all first year college and university students are still at risk and should be vaccinated. For further information, follow the link on the right.
Preventing Meningitis provides information about meningitis, its symptoms and the campaigns that have been organised to help fight the disease. It also includes information about meningococcal septicaemia, the more life-threatening form of meningococcal disease.
The Meningitis C conjugate vaccine (MenC) has been part of the routine childhood immunisation programme since 1999, with uptake levels close to 90%.